Valuation: Quest Laboratories Limited

Market Cap 1.39B 14.53M 12.52M 11.85M 10.74M 20.16M 20.26M 141M 54.13M 706M 54.56M 53.37M 2.23B P/E 2025
12.4x
P/E 2026 11.5x
Enterprise Value 1.34B 14.07M 12.12M 11.48M 10.4M 19.52M 19.61M 136M 52.42M 684M 52.83M 51.67M 2.16B EV / Sales 2025
1.43x
EV / Sales 2026 1.46x
Free-Float
99%
Yield 2025 *
-
Yield 2026 -
1 day+0.89%
1 week-0.94%
Current month-2.87%
1 month-6.41%
3 months-16.18%
6 months-24.38%
Current year-23.07%
1 week 82
Extreme 82
88
1 month 81.3
Extreme 81.3
93
Current year 81.3
Extreme 81.3
152.6
1 year 81.3
Extreme 81.3
152.6
3 years 75.15
Extreme 75.15
196.8
5 years 75.15
Extreme 75.15
196.8
10 years 75.15
Extreme 75.15
196.8
Manager TitleAgeSince
Chief Executive Officer 59 2023-12-31
Director of Finance/CFO 38 2023-12-31
Compliance Officer - 2025-09-02
Director TitleAgeSince
Chairman 59 2023-12-31
Director/Board Member 31 2021-03-04
Director/Board Member 72 2024-01-09
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%-0.94%-13.13% - 14.53M
-0.65%-2.93%+47.70%+86.30% 994B
-0.29%-3.51%+49.15%+61.95% 640B
+0.83%+0.26%+17.76%+70.10% 454B
+4.56%+1.89%+38.36%+38.82% 337B
+2.80%-8.18%+17.96%+26.27% 261B
+3.15%+0.40%+5.92%+11.80% 246B
-1.34%-13.70%+36.53%+46.70% 204B
+1.97%-5.84%-20.73%-58.78% 190B
-0.75%-4.82%+25.46%+85.90% 178B
Average +1.41%-5.28%+20.50%+41.01% 350.48B
Weighted average by Cap. +1.38%-4.42%+32.56%+55.31%

Financials

2025 2026
Net sales 1.04B 10.88M 9.38M 8.88M 8.05M 15.1M 15.17M 105M 40.55M 529M 40.87M 39.97M 1.67B 1.14B 11.96M 10.3M 9.75M 8.84M 16.59M 16.67M 116M 44.55M 581M 44.9M 43.91M 1.84B
Net income 136M 1.42M 1.22M 1.16M 1.05M 1.97M 1.98M 13.76M 5.29M 69.02M 5.33M 5.22M 218M 149M 1.56M 1.34M 1.27M 1.15M 2.16M 2.17M 15.08M 5.8M 75.66M 5.85M 5.72M 239M
Net Debt -191M -2M -1.72M -1.63M -1.48M -2.77M -2.78M -19.35M -7.44M -97.07M -7.5M -7.34M -307M -44M -461K -397K -376K -341K -639K -642K -4.46M -1.72M -22.39M -1.73M -1.69M -70.74M
Logo Quest Laboratories Limited
Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others. It offers dry syrup and suspension, such as Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, Zinc Oral Solution USP, Alpha Amilase & Pepsine, Sucralfate Suspension, and others. Its ointments include Silver Sulphadiazine Cream IP, Diclofenac Diethylamino IP Gel, and Povidone Iodine Ointment USP.
Employees
-
Date Price Change Volume
26-09-11 ₹84.70 +0.89% 2,400
26-09-10 ₹83.95 -3.84% 20,400
26-09-09 ₹87.30 +6.46% 8,400
26-09-08 ₹82.00 0.00% 3,600
26-09-07 ₹82.00 -4.09% 24,000
  1. Stock Market
  2. Stocks
  3. QUESTLAB Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!